Syngene shares unchanged after analyst meeting update
Syngene shares unchanged after analyst meeting update. The company disclosed a recent interaction with analysts and institutional investors, providing general business updates. No financial figures or strategic changes were announced. The filing was routine and did not include material news.
📊 STOCKS: $SYNGENE | 🏢 SECTOR: Pharma | #LOWIMPACT #AnalystMeeting
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.